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Abstract: Background: A 6-month abstinence from alcohol is usu-
ally required before patients with severe alcoholic hepatitis are con-
sidered for liver transplantation. Patients whose hepatitis is not
responding to medical therapy have a 6-month survival rate of
approximately 30%. Since most alcoholic hepatitis deaths occur
within 2 months, early liver transplantation is attractive but
controversial.
Methods: We selected patients from seven centers for early liver
transplantation. The patients had no prior episodes of alcoholic hep-
atitis and had scores of 0.45 or higher according to the Lille model
(which calculates scores ranging from 0 to 1, with a score P0.45
indicating nonresponse to medical therapy and an increased risk of
death in the absence of transplantation) or rapid worsening of liver
function despite medical therapy. Selected patients also had support-
ive family members, no severe coexisting conditions, and a commit-
ment to alcohol abstinence. Survival was compared between patients
who underwent early liver transplantation and matched patients
who did not.
Results: In all, 26 patients with severe alcoholic hepatitis at high risk
of death (median Lille score, 0.88) were selected and placed on the
list for a liver transplant within a median of 13 days after nonre-
sponse to medical therapy. Fewer than 2% of patients admitted for
an episode of severe alcoholic hepatitis were selected. The centers
used 2.9% of available grafts for this indication. The cumulative 6-
month survival rate (±SE) was higher among patients who received
early transplantation than among those who did not (77 ± 8% vs.Journal of Hepatology 20
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E-mail address: andrew.burroughs@nhs.net23 ± 8%, P <0.001). This beneﬁt of early transplantation was main-
tained through 2 years of follow-up (hazard ratio, 6.08; P = 0.004).
Three patients resumed drinking alcohol: one at 720 days, one at
740 days, and one at 1140 days after transplantation.
Conclusions: Early liver transplantation can improve survival in
patients with a ﬁrst episode of severe alcoholic hepatitis not respond-
ing to medical therapy. (Funded by Société Nationale Française de
Gastroentérologie.)
 2012 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.
Severe alcoholic hepatitis (SAH), if there is no response to sup-
portive and steroid therapy, has a mortality rate of 70% within
6 months [1,2], exceeding that of other acute conditions, such
as severe pneumonia. Is there further therapy? There is liver
transplantation used successfully for end stage cirrhosis, includ-
ing alcoholic cirrhosis, and acute liver failure [3] which shares
several clinical features with SAH: renal failure, sepsis and poor
outcomes [3]. Thus, it is a paradox that transplantation has rarely
been used for SAH. The reason is a transposition of current clini-
cal practice for selecting patients with alcoholic cirrhosis for
transplantation, which in many centres requires 6 months of
abstention. A critically important point is that evidence that this
criterion correlates with survival has no documentation [4]. How-
ever, it is associated with a return to drinking alcohol [5],
although disputed by some [4], but which in any case reﬂects a
risk for alcoholism, and not necessarily alcoholic liver disease.
The disassociation may be because the transplanted liver changes
the genetic susceptibility to damage by alcohol [6].
The focus on recidivism due to alcohol, rather than survival as
the primary outcome after transplantation for alcoholic cirrhosis
has been challenged [7], and this would be even more so for SAH.
Indeed, the latter consideration is only valid if there is time for
recovery, avoiding transplantation in some patients. Thus, this
landmark paper [8], which documents a 77% (±8%) survival at
6 months in 26 patients with SAH not responding to steroid ther-
apy followed by liver transplantation, vs. 23% (±8%) in matched
controls (p <0.001) without transplantation, challenges current
medical practice, because it demonstrates a dramatic survival
beneﬁt (also extended to 2 years), and the incongruity of the
‘‘6-month rule’’, for SAH. Franco-Belgian clinicians in seven cen-
tres initiated this study [8], following a consensus [9], applying
strict selection criteria, sensitive to the risk of recidivism, but also
to ‘‘natural justice’’, given the increasing shortage of donor
organs. Thus, they considered patients with SAH for early liver12 vol. 57 j 451–452
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transplantation if there was, histological conﬁrmation (23/3 by
explant histology), non-response to corticosteroids after 7 days
(n = 25), or increasing disease severity (n = 1). In addition, the
admission had to be the ﬁrst liver decompensating event, the
patient had to have close and supportive family, no medical or
psychiatric co-morbidity, and a life-long commitment to absten-
tion (already the case for transplantation of alcoholic cirrhosis).
Furthermore, all nursing and medical teammembers had to agree
to listing without exception – this degree of unanimity is not nec-
essarily achieved for alcoholic cirrhosis – so this was a very strin-
gent criterion. Two centres had prospective data bases on
alcoholic hepatitis, used for case controls (matched age, gender,
disease severity); another 69 patients were randomly matched:
they had a 30 ± 6% month survival. Outcomes after transplanta-
tion were compared to 92 randomly selected responders to med-
ical therapy: survival was 75 ± 4% at 6 months. The decision to
list for liver transplantation took place at a median of 13 days
after diagnosing non-response to steroids, and transplantation
occurred at a median of 9 days after listing.
After transplantation, ﬁve of six deaths were related to infec-
tion, invasive aspergillosis accounting for 4. Thus, antifungal pro-
phylaxis could have further increased survival. The patients had
very close follow-up (median of 11 visits in 6 months). Three
patients resumed drinking at 720, 740, and 1140 days after trans-
plantation – two remained daily consumers (30 g and >50 g/day)
– 1 imbibed 10 g/week. This recidivism rate is similar to that for
alcoholic cirrhosis with 6-month pretransplant abstention [4,5].
The 26 transplanted patients, represented 1.8% of patients with
alcoholic hepatitis, 2.9% of all transplants, and 8.3% of transplants
for alcoholic liver disease [8].
Thus, patients with SAH with non-response to steroids can be
selected for liver transplantation, have good survival (potentially
improved by prophylactic antifungals), and have a low rate of
recidivism with close follow-up. The medical aspects have been
addressed in this study [8]. What needs to change is the abolition
of the ‘‘6-month rule’’, which also needs to be rescinded in severe
alcoholic cirrhosis, with a focus on survival, rather than a return
to drinking per se as the main outcome, still the focus of the
accompanying editorial [10]. The important distinction is a return
to harmful drinking for the graft, family or society. What is also
needed is a transparent and consistent system of allocation of
organs that does not favour, but most importantly does not dis-
criminate against, patients with SAH, thus denying the chance
of survival.
At a societal level, education is needed to explain that alco-
holic liver disease does have a genetic basis [6], and that liver
transplantation is already widely used in other situations of
either deliberate or unknowing self harm: paracetamol and452 Journal of Hepatology 201ecstasy induced acute liver failure, previous intravenous drug
misuse or unprotected sex, in some with hepatitis B and C. Thus,
action is needed from national transplant policy committees, to
promote such education, and to establish that liver transplanta-
tion for SAH is not a subject for research, as to whether it should
take place or not, but only relevant for improving outcomes.
Service development needs to encompass this group of patients,
ensuring access to liver transplantation to save lives, and rein-
forcing follow-up protocols already in use for alcoholic cirrhosis,
that give adequate support to minimize the risk of damaging the
new liver and society.
This ground breaking clinical result [8] demonstrates that sur-
vival outcomes must justiﬁably trump recidivism in considering
patients with SAH for liver transplantation, and thus, selection
and allocation criteria need to change.Conﬂict of interest
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